Pear Therapeutics (PEAR) Institutional Ownership → The “Next Bitcoin”? 10 CENT Crypto Set to Explode (From True Market Insiders) (Ad) Free PEAR Stock Alerts Add Compare Share Share OwnershipStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial MediaStock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsSocial Media Institutional Ownership Changes (13F Filings) for Pear Therapeutics (NASDAQ:PEAR)CurrentInstitutional OwnershipPercentage71.17%Number ofInstitutional Buyers(last 12 months)1TotalInstitutional Inflows(last 12 months)$2.77MNumber ofInstitutional Sellers(last 12 months)0 Get PEAR Insider Trade Alerts Want to know when executives and insiders are buying or selling Pear Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data PEAR Institutional Buying and Selling by Quarter Ad Prosper Trading AcademyThese AI trades triggered this morning (545% return)If you think a market crash is possible in 2024, I don't know why you're not using this yet. Click Here To Get Your Free Copy Pear Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/2/2023Arboretum Ventures LLC10,859,050$2.77M8.2%N/A7.608% 3/23/2023MetLife Investment Management LLC41,941$49K0.0%N/A0.030% 2/13/2023The Manufacturers Life Insurance Company29,233$34K0.0%N/A0.021% 2/2/2023SG Americas Securities LLC25,676$30K0.0%+61.1%0.018% 1/24/2023Darrow Company Inc.154,711$183K0.2%-15.1%0.110% 11/15/2022Verdence Capital Advisors LLC13,815$28K0.0%N/A0.010% 11/8/2022New York State Common Retirement Fund48,590$99K0.0%N/A0.035% 11/3/2022Darrow Company Inc.182,211$371K0.4%N/A0.131% 11/2/2022Daiwa Securities Group Inc.12,737$26K0.0%N/A0.009% 10/31/2022SG Americas Securities LLC15,935$33K0.0%N/A0.011% 10/27/2022US Bancorp DE54,897$112K0.0%N/A0.040% 10/27/2022Strs Ohio15,900$32K0.0%N/A0.011% 10/12/2022 Acropolis Investment Management LLC164,842$336K0.0%N/A0.119% 5/12/2022Magnus Financial Group LLC11,800$60K0.0%N/A0.009% 5/11/2022GSA Capital Partners LLP28,900$146K0.0%N/A0.021% 4/26/2022Sciencast Management LP36,621$190K0.0%N/A0.027% 2/25/2022 EDBI Pte Ltd426,371$2.64M1.4%N/A1.236% 2/14/2022Sarissa Capital Management LP500,356$3.10M0.3%N/A1.450% 2/14/2022SB Global Advisers Ltd12,100,078$75.02M1.5%N/A35.073% 2/9/2022Arboretum Ventures Inc.10,859,050$67.33M38.8%N/A31.476% 2/7/2022 Roble Belko & Company Inc4,502$28K0.0%N/A0.013% 2/3/20225AM Venture Management LLC18,631,771$115.52M21.7%N/A54.005% 1/28/2022BerganKDV Wealth Management LLC4,500$28K0.0%N/A0.013% 1/18/2022 TB Alternative Assets Ltd.2,071,865$12.85M3.8%N/A25.233% (Data available from 1/1/2016 forward) PEAR Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of PEAR shares? During the previous two years, 13 institutional investors and hedge funds held shares of Pear Therapeutics. The most heavily invested institutionals were Arboretum Ventures LLC ($2.77M), Acropolis Investment Management LLC ($336K), Darrow Company Inc. ($183K), GSA Capital Partners LLP ($146K), US Bancorp DE ($112K), New York State Common Retirement Fund ($99K), and Magnus Financial Group LLC ($60K).Learn more on PEAR's institutional investors. What percentage of Pear Therapeutics stock is owned by institutional investors? 71.17% of Pear Therapeutics stock is owned by institutional investors. Learn more on PEAR's institutional investor holdings. Which institutional investors have been buying Pear Therapeutics stock? Of the 13 institutional investors that purchased Pear Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Arboretum Ventures LLC ($10.86M), Darrow Company Inc. ($182.21K), Acropolis Investment Management LLC ($164.84K), US Bancorp DE ($54.90K), New York State Common Retirement Fund ($48.59K), MetLife Investment Management LLC ($41.94K), and The Manufacturers Life Insurance Company ($29.23K). How much institutional buying is happening at Pear Therapeutics? Institutional investors have bought a total of 11,489,592 shares in the last 24 months. This purchase volume represents approximately $4.11M in transactions. Which Pear Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Pear Therapeutics stock in the last 24 months: Darrow Company Inc. ($27.50K). How much institutional selling is happening at Pear Therapeutics? Institutional investors have sold a total of 27,500 shares in the last 24 months. This volume of shares sold represents approximately $32.45K in transactions. Related Companies: VRPX Major Shareholders CING Major Shareholders NAVB Major Shareholders ZVSA Major Shareholders PCSA Major Shareholders GNPX Major Shareholders BIOL Major Shareholders SNES Major Shareholders MBIO Major Shareholders MYMD Major Shareholders This page (NASDAQ:PEAR) was last updated on 4/28/2024 by MarketBeat.com Staff From Our PartnersConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial MetalsThe Best AI Stock to Own in the World Today is Trading for Just $25Banyan Hill PublishingHis win rate puts Warren Buffett to shame… Investing DailyHe Is Giving Away BitcoinCrypto Swap ProfitsThe A.I. story nobody is telling you (Read ASAP)TradeSmithThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyBiden out June 13; Kamala won’t replace him?Paradigm PressJeff Bezos Just Humiliated Elon MuskInvestorPlace Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Pear Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.